Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial from Editor-in-Chief
Volume: 9 Issue: 1
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
Zaenker S. Kurt, Editorial from Editor-in-Chief, Inflammation & Allergy - Drug Targets (Discontinued) 2010; 9 (1) . https://dx.doi.org/10.2174/187152810791292917
DOI https://dx.doi.org/10.2174/187152810791292917 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
11
Related Articles
-
The Potential Prognostic Performance of Neutrophil CD64 and Monocyte HLA-DR in Patients with Complicated Intra-abdominal Infections
Current Immunology Reviews (Discontinued) TNF-α Polymorphisms and Maternal Depression in a Mexican Mestizo Population
CNS & Neurological Disorders - Drug Targets Repositioning Drugs for Rare Immune Diseases: Hopes and Challenges for a Precision Medicine
Current Medicinal Chemistry Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology The Immune Response to the Parasitic Nematode Trichinella and the Ways to Escape it. From Experimental Studies to Implications for Human Infection.
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Can Anthropometric and Body Composition Measurements During Pregnancy be Used to Predict Preeclampsia Risk?
Current Women`s Health Reviews Clinical Aspects of Tumor Necrosis Factor-α Signaling in Hepatocellular Carcinoma
Current Pharmaceutical Design HIV Management: New Approaches
Current Drug Therapy Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials Uveitis in Horses, Rats and Man: What Do We Learn from Our Pets?
Current Immunology Reviews (Discontinued) The Role of ROS and RNS in Regulating Life and Death of Blood Monocytes
Current Pharmaceutical Design From Solvent to Sustainable Catalysis - Chloroferrate Ionic Liquids in Synthesis
Current Organic Synthesis The Multiple Aspects of Stroke and Stem Cell Therapy
Current Molecular Medicine Probiotics and Different Efficacy, How it can be Managed?
Current Drug Therapy Upon the Developments of Drug-Eluting Stents in the Treatment of Coronary Lesions
Recent Patents on Materials Science Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents
Current Drug Targets Immunomodulatory Drugs as a Therapy for Multiple Myeloma
Current Pharmaceutical Biotechnology Adverse Drug Reactions in Critical Care Settings: A Systematic Review
Current Drug Safety Coenzyme Q10: A Potential Adjunct for Treatment of Antiphospholipid Syndrome and Recurrent Miscarriage
Current Immunology Reviews (Discontinued) Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma
MicroRNA